- Home
- PERF vs BDTX Comparison
PERF vs BDTX Comparison
Compare PERF & BDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PERF
- BDTX
- Stock Information
- Founded
- PERF 2015
- BDTX 2014
- Country
- PERF Taiwan
- BDTX United States
- Employees
- PERF N/A
- BDTX N/A
- Industry
- PERF Computer Software: Prepackaged Software
- BDTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PERF Technology
- BDTX Health Care
- Exchange
- PERF Nasdaq
- BDTX Nasdaq
- Market Cap
- PERF 197.6M
- BDTX 161.6M
- IPO Year
- PERF N/A
- BDTX 2020
- Fundamental
- Price
- PERF $1.85
- BDTX $2.52
- Analyst Decision
- PERF Buy
- BDTX Strong Buy
- Analyst Count
- PERF 2
- BDTX 4
- Target Price
- PERF $4.00
- BDTX $15.50
- AVG Volume (30 Days)
- PERF 59.2K
- BDTX 547.5K
- Earning Date
- PERF 10-29-2024
- BDTX 11-05-2024
- Dividend Yield
- PERF N/A
- BDTX N/A
- EPS Growth
- PERF N/A
- BDTX N/A
- EPS
- PERF 0.05
- BDTX N/A
- Revenue
- PERF $58,445,000.00
- BDTX N/A
- Revenue This Year
- PERF $15.77
- BDTX N/A
- Revenue Next Year
- PERF $13.89
- BDTX N/A
- P/E Ratio
- PERF $36.84
- BDTX N/A
- Revenue Growth
- PERF 15.84
- BDTX N/A
- 52 Week Low
- PERF $1.70
- BDTX $2.16
- 52 Week High
- PERF $3.77
- BDTX $7.66
- Technical
- Relative Strength Index (RSI)
- PERF 46.80
- BDTX 29.57
- Support Level
- PERF $1.78
- BDTX $3.16
- Resistance Level
- PERF $1.92
- BDTX $3.44
- Average True Range (ATR)
- PERF 0.08
- BDTX 0.22
- MACD
- PERF 0.00
- BDTX -0.03
- Stochastic Oscillator
- PERF 45.63
- BDTX 10.62
About PERF Perfect Corp.
Perfect Corp is engaged in the beauty and fashion tech revolution, providing omni-channel integrated solutions that are ultra-personalized, interactive and engaging, from online to in-store through beauty mirrors. Geographically, the company has a presence in the United States, France, Japan and Others.
About BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a precision oncology medicine company. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.